Spark Therapeutics, Inc. (ONCE): Bullish Rating Reiterated

ONCE – Credit Suisse reiterates Outperform rating; PT raised to $75 from $61. This price target represents a 16.28% upside over the stock’s previous closing price of $64.50.

Update: As of Sep. 21, 2018, this bullish analyst call has returned -13.88%.

Key Facts Surrounding This News Item

  • ONCE had a POWR Rating of C (Neutral) coming into today.
  • ONCE was 7.14% above its 10-Day Moving Average coming into today.
  • ONCE was 13.73% above its 20-Day Moving Average coming into today.
  • ONCE was 17.08% above its 50-Day Moving Average coming into today.
  • ONCE was 1.83% above its 100-Day Moving Average coming into today.
  • ONCE was -3.93% below its 200-Day Moving Average coming into today.
  • ONCE had returned +25.44% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Spark Therapeutics, Inc. (ONCE)

Spark Therapeutics is a gene therapy leader seeking to transform the lives of patients suffering from debilitating genetic diseases by developing one-time, life-altering treatments. The company was founded in 2013 and is based in Philadelphia, Pennsylvania. View our full ONCE ticker page with ratings, news, and more.

Try Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

ONCE at a Glance

ONCE Current POWR Rating™
Overall POWR Rating™
ONCE Current Price $55.55 2.85%
More ONCE Ratings, Data, and News

ONCE Price Reaction

The day of this event (Mar. 8, 2018)
ONCE Closing Price$62.72 2.76%
ONCE Volume563,700
4.47% from avg
Leading up to this event
ONCE 1-mo return26.40%
After this event
ONCE 1-day return4.74%
ONCE 3-day return1.37%
ONCE 5-day return0.62%

ONCE Price Chart

More Spark Therapeutics, Inc. (ONCE) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ONCE News
Page generated in 1.7621 seconds.